The Cosmc connection to the Tn antigen in cancer
Open accessThe DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Abstract
The Tn antigen is a tumor-associated carbohydrate antigen that is not normally expressed in peripheral tissues or blood cells. Expression of this antigen, which is found in a majority of human carcinomas of all types, arises from a blockage in the normal O-glycosylation pathway in which glycans are extended from the common precursor GalNAcα1-O-Ser/Thr (Tn antigen). This precursor is generated in the Golgi apparatus on newly synthesized glycoproteins by a family of polypeptide α-N-acetylgalactosaminyltransferases (ppGalNAcTs) and then extended to the common core 1 O-glycan Galβ1-3GalNAcα1-O-Ser/Thr (T antigen) by a single enzyme termed the T-synthase (core 1 β3-galactosyltransferase or C1GalT). Formation of the active form of the T-synthase requires a unique molecular chaperone termed Cosmc, encoded by Cosmc on the X-chromosome (Xq24 in humans, Xc3 in mice). Cosmc resides in the endoplasmic reticulum (ER) and prevents misfolding, aggregation, and proteasome-dependent degradation of newly synthesized T-synthase. Loss of expression of active T-synthase or Cosmc can lead to expression of the Tn antigen, along with its sialylated version Sialyl Tn antigen as observed in several cancers. Both genetic and epigenetic pathways, in addition to potential metabolic regulation, can result in abnormal expression of the Tn antigen. Engineered expression of the Tn antigen by disruption of either C1GalT (T-syn) or Cosmc in mice is associated with a tremendous range of pathologies and engineered expression of the Tn antigen in mouse embryos leads to embryonic death. Studies indicate that many membrane glycoproteins expressing the Tn antigen and/or truncated O-glycans may be dysfunctional, due to degradation and/or misfolding. Thus, expression of normal O-glycans is associated with health and homeostasis whereas truncation of O-glycans, e.g. the Tn and/or Sialyl Tn antigens is associated with cancer and other pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–206 of 206
Loaiza‐Bonilla, A., Horowitz, D., Sheela, S., Baral, A., Tinoco, G., & Kyriakopoulos, C. P. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-8 · Cited by 10 · cited 1×
“Other laboratories have confirmed these findings and identified additional patients with mutations in Cosmc [83,95].”
Biodistribution of HuCC49ΔCH2-β-galactosidase in colorectal cancer xenograft model
Yu, Y., Fang, L., & Sun, D. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.020 · Cited by 8 · cited 1×
“Although some studies showed that the antibody distributed mainly in the xenografts of human tumors in mice [178,196] and in human CRC [197], Sialyl T antigen is a normal O-glycan and reactivity to normal tissue is a major concern.”
Hamilton, S. R. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.02.007 · Cited by 7
Characterization of cell surface antigens expressed in the HMA-1 breast cancer cell line
Ohuchi, N., Harada, Y., Masuko, T., Matano, S., & Mori, S. (1995) · Surgery Today · doi:10.1007/bf00311535 · Cited by 5 · cited 1×
“Human tumor-associated glycoprotein-72 (TAG-72) is a carcinoma mucin molecule expressed in colon [184,185], breast [186], pancreatic [187], ovarian [188], lung, and gastric cancers [189].”
Management of patients with ovarian cancer using monoclonal antibodies
Lastoria, S., Panza, N., Esposito, G., Vergara, E., Castelli, L., Caracò, C., Battista, C., Pacilio, G., & Salvatore, M. (1992) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(92)90003-p · Cited by 4 · cited 1×
“Human tumor-associated glycoprotein-72 (TAG-72) is a carcinoma mucin molecule expressed in colon [184,185], breast [186], pancreatic [187], ovarian [188], lung, and gastric cancers [189].”
Yuan, M. (1989) · PubMed · Cited by 4
Research works printed but not linked: 2
- [84]Ju T Otto VI Cummings RD The Tn antigen-structural simplicity and biological complexity Angew Chem Int Ed Engl 2011 50 8 1770 91 21259410 PMC7159538
- [87]Friedenreich V The Thomsen Hemagglutination Phenomenon: Production of a Specific Receptor Quality in Red Corpuscles by Bacterial Activity Dissertation Thesis Copenhagen Levin and Munksgaard 1930
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Disruption of this layer by genetically altering mucin backbones, O-linked glycosyltransferases (or key chaperones like Cosmc) can have very serious consequences, including inflammation and carcinogenesis associated with microbial invasion (453) (454) (455) (456) .”
BackgroundProtein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
“Once folded properly, the T-synthase moves to the Golgi apparatus, where it acts quantitatively on the products of the ppGalNAcTs to generate normal O-glycans (102).”
BackgroundInfluentialSelf-citationHallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
“Cancer cells characteristically express proteins with truncated O-glycan structures that are thought to be due to mutations or epigenetic silencing of the COSMC gene [95, 96], or to increased expression of ST6GalNAc1 [88].”
BackgroundSialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Kudelka, M. R., Stowell, S. R., Cummings, R. D., & Neish, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0331-7 · Cited by 355
Self-citation
Metadata
- Authors
- Ju, T., Aryal, R. P., Kudelka, M. R., Wang, Y., & Cummings, R. D.
- Affiliations
- Emory University (US)
- Corresponding author
- Cummings, Richard D.
- Venue
- Cancer Biomarkers
- Publisher
- SAGE Publications
- Published
- 2014-02-27
- Volume
- 14
- Issue
- 1
- Pages
- 63-81
- ISSN
- 1574-0153 (ISSN-L)
- 1875-8592
- PMC
- PMC5808877
- OpenAlex
- W1544375765
- Cited by
- 153
- References
- 202
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 11 · 2023: 22 · 2022: 14 · 2021: 14 · 2020: 18 · 2019: 14 · 2018: 10 · 2017: 5 · 2016: 11 · 2015: 7 · 2014: 2
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- Locations
- Cancer Biomarkers (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (U01CA168930)
- National Institute of General Medical Sciences (T32GM008169, R24GM098791)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Tn antigen, sialyl-Tn antigen, Cosmc, T-synthase, O-glycosylation, tumor-associated carbohydrate antigens, X chromosome, molecular chaperones, protein misfolding, epigenetic regulation
- MeSH terms
- Animals, Carbohydrate Sequence, Glycosylation, Humans, Neoplasms, Polysaccharides, Antigens, Tumor-Associated, Carbohydrate, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.